Invitrogen™ Human Lp-PLA2/PLA2G7/PAF-AH ELISA Kit

Ref.: BL-RE-093233Manufacturer ref.: EH304RBX5 5 x 96 tests
€2,950.00 excl. VAT

Human Lp-PLA2/PLA2G7/PAF-AH quantitates human Lp-PLA2/PLA2G7/PAF-AH in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Lp-PLA2/PLA2G7/PAF-AH.

Accession number
1-alkyl-2-acétylglycérophosphocholine estérase ; 2-acétyl-1-alkylglycérophosphocholine estérase ; phospholipase A2 du groupe VIIA ; gVIIA-PLA2 ; phospholipase associée aux LDL A2 ; LDL-PLA(2) ; LDL-PLA2 ; phospholipase associée aux lipoprotéines A2 ; LP-PLA2 ; PAF 2-acylhydrolase ; PAF acétylhydrolase ; PAFAD ; PAFAH ; phospholipase A2 du groupe VII ; phospholipase A2, groupe VII (acétylhydrolase du facteur d’activation plaquettaire, plasma) ; PLA2G7 ; acétylhydrolase du facteur d’activation plaquettaire ; R75400
Dose range
8.19 to 2.000 pg/ml
Sensitivity of the dosage
8.1 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human Lp-PLA2/PLA2G7/PAF-AH quantitates human Lp-PLA2/PLA2G7/PAF-AH in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Lp-PLA2/PLA2G7/PAF-AH.

Human Lp-PLA2/PLA2G7/PAF-AH quantitates human Lp-PLA2/PLA2G7/PAF-AH in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Lp-PLA2/PLA2G7/PAF-AH.

PLA2G7 code a protein that is a secreted enzyme that catalyzes the degradation of platelet activation factor into biologically inactive products. The defects of this gene are a cause of acetylhydrolase deficiency of platelet activation factor.

Sensitivity

Sensitivity of dosage: 8.1 ng/ml.

Measurement range

Dose range: 8.19 to 2.000 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: PLA2G7.

Samples

Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; serum, 50 µl; plasma, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17105079
Specifications
Accession number1-alkyl-2-acetylglycerophosphocholine esterase; 2-acetyl-1-alkylglycerophosphocholine esterase; phospholips A2 in group VIIA; gVIIA-PLA2; phospholipsase in association with LDL A2; LDL-PLA(2); LDL-PLA2; phospholipsase associated with lipoproteins A2; LP-PLA2; PAF 2-acylhydrolase; PAF acetylhydrola
Dose range8.19 to 2.000 pg/ml
Sensitivity of the dosage8.1 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)Q13093
Gene symbol(s)PLA2G7
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetPLA2G7
Test time1 h 20 min
Physical characteristics
Volume of sampleSupernatant, 50 µl; serum, 50 µl; plasma, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH304RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.